Results 201 to 210 of about 48,636 (289)

Long‐term outcomes of electrical storm patients listed for urgent heart transplantation but not transplanted acutely

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Refractory electrical storm (ES) is a life‐threatening condition in which heart transplantation (HTx) can be proposed. Nevertheless, the shortage of donors and subsequent outcomes question its place as a rescue strategy. We aim to describe the prognosis of ES patients listed for HTx but not transplanted.
Miloud Cherbi   +11 more
wiley   +1 more source

In heart failure, echocardiographic parameters of right ventricular function are powerful tools to predict renal failure

open access: yesESC Heart Failure, EarlyView.
Abstract Background Chronic kidney disease (CKD) has a high prevalence in patients with heart failure (HF) and is associated with prolonged hospitalization, increased need for intensive care and mortality. There is an urgent need to identify factors that influence the interaction between heart and kidney disorders, often described as cardiorenal ...
Alexander Reinecke   +7 more
wiley   +1 more source

Mitral valve transcatheter edge‐to‐edge repair in the elderly—A safe and effective therapy

open access: yesESC Heart Failure, EarlyView.
Mitral valve transcatheter edge‐to‐edge repair in elderly patients is safe and offers comparable mitral valve regurgitation reduction and symptom relief to younger patients. At 3 years, increased all‐cause mortality is observed in elderly patients with advanced heart failure and elevated EuroSCORE II.
Dominik Felbel   +6 more
wiley   +1 more source

Inter‐atrial block as a predictor of adverse outcomes in patients with HFpEF

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Inter‐atrial block (IAB), a marker of electrical atrial dysfunction, is associated with an increased risk of atrial fibrillation (AF) and adverse events in various populations. The prognostic impact of IAB in heart failure (HF) with preserved ejection fraction (HFpEF) remains unknown.
Jerremy Weerts   +11 more
wiley   +1 more source

Long‐term outcomes of apixaban as main anticoagulant in patients with HeartMate 3 left ventricular assist devices

open access: yesESC Heart Failure, EarlyView.
Abstract Aims HeartMate 3 (HM3) left ventricular assist devices (LVADs) offer improved haemocompatibility‐related outcomes for end‐stage heart failure patients, facilitating the exploration of alternative anticoagulation therapies beyond warfarin.
Jennifer Jdaidani   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy